Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT05279768

Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

Potential Use of Umbilical Cord Mesenchymal Stem Cells and Secretoms for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

Sponsor: PT. Prodia Stem Cell Indonesia

Conditions Polycystic Ovary Syndrome

Interventions Control Secretomes UC-MSCs UC-MSCs and Secretomes

Updated 6 times since 2022 Last updated: Feb 23, 2026 Started: Sep 1, 2022 Primary completion: Jan 20, 2025 Completion: Jan 20, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05279768, this PHASE1/PHASE2 trial focuses on Polycystic Ovary Syndrome and remains completed. Sponsored by PT. Prodia Stem Cell Indonesia, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Completed PHASE1/PHASE2

Status: Unknown → Completed
Oct 2024 — Feb 2026 [monthly]

Unknown PHASE1/PHASE2

Status: Recruiting → Unknown
Sep 2024 — Oct 2024 [monthly]

Recruiting PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Sep 2022 — Jul 2024 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Apr 2022 — Sep 2022 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PT. Prodia Stem Cell Indonesia

Data source: PT. Prodia Stem Cell Indonesia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia